Copyright
©The Author(s) 2017.
World J Gastroenterol. Oct 14, 2017; 23(38): 7009-7015
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.7009
Published online Oct 14, 2017. doi: 10.3748/wjg.v23.i38.7009
Group | n | Annexin II positive | Positive rate, % | P value |
Age in yr | ||||
≤ 60 | 27 | 23 | 85.2 | > 0.05 |
> 60 | 24 | 19 | 79.2 | |
Sex | ||||
Male | 31 | 27 | 87.1 | > 0.05 |
Female | 20 | 15 | 75 | |
Tumor diameter in cm | ||||
≤ 5 | 19 | 12 | 63.2 | < 0.05 |
> 5 | 32 | 30 | 93.8 | |
Differentiation | ||||
Well differentiated | 15 | 9 | 60 | < 0.05 |
Poorly differentiated | 36 | 33 | 91.7 | |
Clinical stage | ||||
I+ II period | 17 | 10 | 58.8 | < 0.05 |
III + IV period | 34 | 32 | 94.1 | |
Lymph node metastasis | ||||
Have | 33 | 31 | 93.9 | < 0.05 |
Not have | 18 | 11 | 61.1 |
- Citation: Han F, Shrestha S, Huang H, Lv HY, Nie C, Lin L, Lu ML. Expression of annexin II in gastric carcinoma and its role in gastric cancer metastasis. World J Gastroenterol 2017; 23(38): 7009-7015
- URL: https://www.wjgnet.com/1007-9327/full/v23/i38/7009.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i38.7009